Harbour Investments’s Transmedics TMDX Stock Holding History

Harbour Investments’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.15K	Buy	82 +81	+8,100%	+$10.6K	﹤0.01%	3366
2025 Q4	$122	Buy	+1	New	+$125	﹤0.01%	3725

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harbour Investments's TMDX Position: Q1 2026 in Review

Harbour Investments increased its Transmedics (TMDX) stake by 8,100% in Q1 2026, buying an estimated $10.6K and bringing the position to 82 shares worth $8.15K. The position accounts for ﹤0.01% of the portfolio, ranked #3366.

Harbour Investments first reported a position in TMDX in Q4 2025 and has held it in 2 quarters since. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

Harbour Investments held 82 shares of Transmedics worth $8.15K as of Q1 2026.
Harbour Investments bought 81 Transmedics shares in Q1 2026, an estimated $10.6K.
Transmedics made up ﹤0.01% of Harbour Investments's portfolio in Q1 2026, its #3366 holding.
Harbour Investments first reported a position in Transmedics in Q4 2025 and has held it in 2 quarters since.
414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.